UBS Group
CHRA

UBS Group’s Charah Solutions, Inc Common Stock CHRA Stock Holding History

UBS Group’s Portfolio CHRA Stock Details CHRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-957
Closed -$5.17K – 11545
2022
Q4 		$5.17K Buy
+957
New +$11.4K ﹤0.01% 9209
2022
Q2 		– Sell
-281
Closed -$14K – 11482
2022
Q1 		$14K Sell
281
-139
-33% -$7.12K ﹤0.01% 8003
2021
Q4 		$20K Buy
420
+411
+4,567% +$18.7K ﹤0.01% 7874
2021
Q3 		$0 Buy
+9
New +$426 ﹤0.01% 10441
2021
Q1 		– Sell
-8
Closed – – 9710
2020
Q4 		$0 Sell
8
-21
-72% -$615 ﹤0.01% 8946
2020
Q3 		$1K Sell
29
-3
-9% -$84 ﹤0.01% 7878
2020
Q2 		$1K Sell
32
-635
-95% -$11K ﹤0.01% 7845
2020
Q1 		$11K Sell
667
-600
-47% -$14K ﹤0.01% 6893
2019
Q4 		$31K Buy
1,267
+568
+81% +$12K ﹤0.01% 6624
2019
Q3 		$15K Buy
699
+513
+276% +$20.2K ﹤0.01% 6920
2019
Q2 		$10K Buy
+186
New +$10.8K ﹤0.01% 7095
2019
Q1 		– Sell
-264
Closed -$22K – 8339
2018
Q4 		$22K Buy
264
+81
+44% +$5.82K ﹤0.01% 6723
2018
Q3 		$14K Buy
+183
New +$14.7K ﹤0.01% 7015

Other funds holding CHRA

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group's CHRA Position: Q1 2023 in Review

UBS Group sold out of Charah Solutions, Inc Common Stock (CHRA) in Q1 2023, closing a stake of 957 shares — an estimated $5.17K sold.

UBS Group first reported a position in CHRA in Q3 2018 and held it in 13 quarters. The position peaked at $31K in Q4 2019. 12 funds tracked by Wall St. Rank hold CHRA as of Q1 2023.

  • UBS Group reported no remaining Charah Solutions, Inc Common Stock position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 957 Charah Solutions, Inc Common Stock shares in Q1 2023, an estimated $5.17K.
  • UBS Group first reported a position in Charah Solutions, Inc Common Stock in Q3 2018 and held it in 13 quarters.
  • UBS Group's Charah Solutions, Inc Common Stock position peaked at $31K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Charah Solutions, Inc Common Stock as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.